Dr. Arash Salardini, MD

Dr. Salardini practices at UT Health Medical Arts and Research Center in San Antonio, Texas.

Dr. Salardini's NPI, 1073749776, was assigned on June 9, 2009. Dr. Salardini graduated from University of New South Wales Faculty of Medicine in 1999. Dr. Salardini's Texas license number on file is S8383.

Dr. Salardini's primary practice is UT Health Medical Arts and Research Center, at 8300 Floyd Curl Dr, San Antonio, TX 78229 in Bexar County. The practice phone is (210) 450-9030.

Dr. Salardini's primary practice is UT Health Medical Arts and Research Center in San Antonio, Texas. Dr. Salardini is also affiliated with University Hospital. The medical group on file is UT Health Physicians. Dmand AI also links Dr. Salardini to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salardini practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Salardini's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Salardini is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Salardini's licenses on file in 3 states: Texas, Connecticut and Florida.

Dmand AI lists alzheimer's disease, cerebrovascular disease, non-alzheimer's dementia (chronic), parkinson's disease and sleep apnea among the conditions Dr. Salardini treats.

CMS data shows 321 Medicare services from Dr. Salardini across 4 procedure codes in 2024, for 168 Medicare patients. Medicare paid $27,083 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Salardini in 2024. The largest group is 75 to 84, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Salardini's median patient age at 76, with 56% women.

In 2024, Dr. Salardini wrote 1,012 Medicare Part D claims for 170 patients. 98% of them were for generic drugs. CMS names the drug for 955 of them, across 13 drugs with 11 or more claims each, at $78,858 in total drug cost. In 2023, CMS named 832 claims across 12 drugs.

Dr. Salardini accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salardini as offering telehealth.

Dmand AI links 35 papers to Dr. Salardini, published from 2009 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Carcinoma, Squamous Cell, Brain and Cognitive Dysfunction. Dr. Salardini has published most often in Alzheimers Dement. Dr. Salardini's most frequent co-authors are Sudha Seshadri, MD, Bahman Jabbari, MD and Randall John Bateman, MD.

Dmand AI links Dr. Salardini to 2 clinical trials. Conditions studied include Alzheimer Disease, Diabetic Angiopathies and Diabetes Complications. Yale University sponsors the most, 2.

CMS Open Payments shows 114 general payments to Dr. Salardini from 8 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Eli Lilly and Company paid the most, $109,643.

Dr. Salardini graduated from University of New South Wales Faculty of Medicine in 1999.

Dr. Salardini is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.